Current clinical practice in corneal crosslinking for treatment of progressive keratoconus in four Nordic countries.

ABSTRACT:

Purpose

To evaluate clinical practice in the diagnosis and treatment of progressive keratoconus with corneal crosslinking (CXL) in four Nordic countries.

Methods

A questionnaire was sent to all centres at which keratoconus patients are evaluated and CXL is performed in Sweden, Denmark, Norway and Iceland. Nineteen of 20 centres participated.

Results

CXL is performed approximately 1300 times per year in these four Nordic countries with a population of around 21.7 million (2019). In most cases, progression is evaluated using the Pentacam HR, and the maximum keratometry reading (K_max ) is considered the most important parameter. The most frequently used treatment protocol in Scandinavia is the 9 mW/cm² epi-off protocol, using hydroxylpropyl methylce

SUBMITTER: Gustafsson I 

PROVIDER: S-EPMC10084360 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature